Our team is working passionately toward improving public health.

RAJEEV VENKAYYA, MD

President, Takeda Vaccine Business

Rajeev is President of the Takeda Vaccine Business. He joined Takeda in 2012 to launch the global vaccine business. He was previously Director of Vaccine Delivery in the Global Health Program at the Bill & Melinda Gates Foundation, and prior to that, Special Assistant to the President for Biodefense at the White House.

JOHN BOSLEGO, MD

Head of Development

John is Head of Development for the Takeda Vaccine Business. His prior experience includes Director of the Vaccine Development Global Program at PATH, Executive Director at Merck Research Laboratories and the Deputy Director at the Walter Reed Army Institute of Research in Washington, DC.

Rahul Singhvi, ScD, MBA

Chief Operating Officer and Head of Vaccine Operations

Rahul is Chief Operating Officer, leads the Vaccine Operations team, and is responsible for the global supply of vaccines at Takeda. He has a wealth of experience in vaccine development and manufacturing. Before joining Takeda, Rahul was President and CEO of Novavax.

Gary Dubin, MD

Head of Global Medical Office

Gary is Head of the Global Medical Office, and leads the Takeda Vaccine Business Medical Affairs and Policy team. He is responsible for vaccines safety and medical governance. Before joining Takeda, Gary spent the previous 20 years at GSK Vaccines.

Hansi Dean, PhD

Head of Discovery Research

Hansi is Head of Discovery Research for the Takeda Vaccine Business. Hansi joined Takeda in 2014. She was previously Director of New Alliances at the International AIDS Vaccine Initiative, and prior to that a Director at PowderJect and Group Leader for Viral Vaccine Development at Schering Plough.

Tetsu Inada, BS, MBA

Head of Finance

Tetsu has been Head of Finance for the Takeda Vaccine Business since 2013. Prior to that Tetsu was at Millennium Pharmaceuticals since 2001, and he joined Takeda through the acquisition of Millennium in 2008.

TAKAYUKI NAKANO, PhD, MBA

Head of Business Planning, Japan Business Coordinator

Takayuki is Head of Business Planning and Japan Business Coordinator. As Head of Business Planning, Takayuki is responsible for business strategy planning, vaccine portfolio management and ensuring organizational governance. As Japan Business Coordinator, he works on strengthening coordination between Japan-based functions and their global counterparts. Takayuki joined Takeda in 2000 and worked in Takeda’s R&D organization prior to joining the Vaccine business.

Paula Blalock

Head of Vaccine Quality

Paula is the Head of Quality for the Takeda Vaccine Business. She has 35 years of pharmaceutical experience in various functional roles, including manufacturing, quality control microbiology and local/global quality assurance roles at Pfizer, Wyeth and Alcon. Her experience includes international on-site assignments and responsibility for global sites and service providers.

Claudia Kelly, MBA, MPH

Interim Head of Global Commercial and Head of Global Market Access

Claudia is the Interim Head of Global Commercial and Head of Global Market Access for the Takeda Vaccine Business. Claudia has more than 20 years of experience in corporate and global roles including product strategy, franchise management, pricing strategy, market access, medical affairs, and commercial operations. Prior to joining Takeda in 2017, she worked on numerous vaccine launches for Merck & Co, the Novartis Vaccine Division and Seqirus.

Amy Atwood

Head of Vaccine Communications

Amy is Head of Communications for the Takeda Vaccine Business, prior to which she was Director of Public Relations for Takeda’s Global Oncology Business Unit. Amy has more than 20 years of experience in all facets of corporate communications, including communication leadership roles at Genzyme, Sanofi Oncology and National Grid.